KORU Medical Systems (KRMD) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.00, -0.99% vs the prior close of $3.03.
- Volume 165.23K shares, 0.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
KRMD dips 1.0% to $3.00. Closed at $3.00, -0.99% vs the prior close of $3.03. Day range $2.96–$3.06, opened at $3.03.
KRMD daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — KRMD dips 1.0% to $3.00
- Closed at $3.00, -0.99% vs the prior close of $3.03. Day range $2.96–$3.06, opened at $3.03.
- Volume was 165.23K shares, 0.6x its 50-day average of 272.43K.
- Price is -5.8% vs its 50-day average ($3.19) and -27.7% vs its 200-day average ($4.15).
- 52-week range $2.86–$6.61; today's close sits at 4% of that range, 54.6% below the 52-week high.
Oct 15, 2026 — KRMD dips 2.6% to $3.03
- Closed at $3.03, -2.57% vs the prior close of $3.11. Day range $2.97–$3.14, opened at $3.12.
- Volume was 203.20K shares, 0.7x its 50-day average of 271.03K.
- Price is -5.2% vs its 50-day average ($3.20) and -27.2% vs its 200-day average ($4.16).
- 52-week range $2.86–$6.61; today's close sits at 5% of that range, 54.1% below the 52-week high.
Oct 14, 2026 — KRMD jumps 3.7% to $3.11, 3 up days in a row
- Closed at $3.11, +3.67% vs the prior close of $3.00. Day range $2.89–$3.11, opened at $2.97.
- Volume was 315.70K shares, 1.2x its 50-day average of 267.13K.
- Price is -3.4% vs its 50-day average ($3.22) and -25.5% vs its 200-day average ($4.18).
- 52-week range $2.86–$6.61; today's close sits at 7% of that range, 52.9% below the 52-week high.
- That makes 3 straight gains.
Oct 13, 2026 — KRMD rises 1.0% to $3.00
- Closed at $3.00, +1.01% vs the prior close of $2.97. Day range $2.93–$3.05, opened at $2.97.
- Volume was 318.00K shares, 1.2x its 50-day average of 263.61K.
- Price is -7.4% vs its 50-day average ($3.24) and -28.4% vs its 200-day average ($4.19).
- 52-week range $2.86–$6.61; today's close sits at 4% of that range, 54.6% below the 52-week high.
Oct 12, 2026 — KRMD rises 0.3% to $2.97
- Closed at $2.97, +0.34% vs the prior close of $2.96. Day range $2.87–$2.97, opened at $2.96.
- Volume was 162.90K shares, 0.6x its 50-day average of 262.84K.
- Price is -9.1% vs its 50-day average ($3.27) and -29.4% vs its 200-day average ($4.21).
- 52-week range $2.86–$6.61; today's close sits at 3% of that range, 55.1% below the 52-week high.
Oct 9, 2026 — KRMD dips 1.3% to $2.96
- Closed at $2.96, -1.33% vs the prior close of $3.00. Day range $2.94–$3.07, opened at $2.99.
- Volume was 202.60K shares, 0.8x its 50-day average of 260.52K.
- Price is -10.0% vs its 50-day average ($3.29) and -30.0% vs its 200-day average ($4.23).
- 52-week range $2.86–$6.61; today's close sits at 3% of that range, 55.2% below the 52-week high.
Oct 8, 2026 — KRMD rises 0.7% to $3.00
- Closed at $3.00, +0.67% vs the prior close of $2.98. Day range $2.95–$3.05, opened at $2.97.
- Volume was 235.90K shares, 0.9x its 50-day average of 258.21K.
- Price is -9.4% vs its 50-day average ($3.31) and -29.3% vs its 200-day average ($4.24).
- 52-week range $2.86–$6.61; today's close sits at 4% of that range, 54.6% below the 52-week high.
Oct 7, 2026 — KRMD dips 0.7% to $2.98
- Closed at $2.98, -0.67% vs the prior close of $3.00. Day range $2.96–$3.05, opened at $2.98.
- Volume was 111.00K shares, 0.4x its 50-day average of 258.71K — lighter than usual.
- Price is -10.6% vs its 50-day average ($3.33) and -30.0% vs its 200-day average ($4.26).
- 52-week range $2.86–$6.61; today's close sits at 3% of that range, 54.9% below the 52-week high.
Oct 6, 2026 — KRMD dips 0.3% to $3.00
- Closed at $3.00, -0.33% vs the prior close of $3.01. Day range $2.95–$3.02, opened at $3.02.
- Volume was 129.10K shares, 0.5x its 50-day average of 259.29K — lighter than usual.
- Price is -10.5% vs its 50-day average ($3.35) and -29.8% vs its 200-day average ($4.27).
- 52-week range $2.86–$6.61; today's close sits at 4% of that range, 54.6% below the 52-week high.
Oct 5, 2026 — KRMD rises 1.7% to $3.01
- Closed at $3.01, +1.69% vs the prior close of $2.96. Day range $2.91–$3.03, opened at $2.99.
- Volume was 206.40K shares, 0.8x its 50-day average of 259.55K.
- Price is -10.8% vs its 50-day average ($3.38) and -29.7% vs its 200-day average ($4.28).
- 52-week range $2.86–$6.61; today's close sits at 4% of that range, 54.4% below the 52-week high.
Oct 2, 2026 — KRMD dips 2.0% to $2.96
- Closed at $2.96, -1.99% vs the prior close of $3.02. Day range $2.94–$3.26, opened at $3.11.
- Volume was 273.50K shares, 1.1x its 50-day average of 257.33K.
- Price is -12.7% vs its 50-day average ($3.39) and -31.1% vs its 200-day average ($4.30).
- 52-week range $2.86–$6.61; today's close sits at 3% of that range, 55.2% below the 52-week high.
KRMD latest news & SEC filings
Every SEC filing by or about KRMD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Manko Joseph M. Jr. & Horton Capital Management, Llc & Horton Capital Partners, Llc & Horton Capital Partners Fund, L.P. received an award of 5,119 shares on Sep 30, 2026; now holds 5,074,660
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Cascella Robert received an award of 5,119 shares at $2.93 (≈$15.00K) on Oct 1, 2026; now holds 103,274
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Matin Shahriar received an award of 5,119 shares at $2.93 (≈$15.00K) on Oct 1, 2026; now holds 106,263
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Fletcher R John received an award of 7,679 shares at $2.93 (≈$22.50K) on Oct 1, 2026; now holds 239,836
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Wholihan Edward received an award of 5,119 shares at $2.93 (≈$15.00K) on Oct 1, 2026; now holds 56,431
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- French Donna received an award of 5,119 shares at $2.93 (≈$15.00K) on Oct 1, 2026; now holds 103,633
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $12.05M (prior year $10.19M) (+18.2% vs Jun 30, 2025)
- Net income: $252.45K (prior year -$206.87K) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.01 (prior year $0.00)
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 29, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Things to know before you trade KRMD
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Mar 12, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.64% (largest 4.7%).
- Liquidity: about 270.37K shares (≈$811.11K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.00 vs a range of $2.86–$6.61 (4% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Adam R Kalbermatten bought 32,000 shares on Sep 8, 2026.
- Latest filings: 8-K Aug 14, 2026; 10-Q Aug 5, 2026; 8-K Aug 5, 2026.
- Share count: 46.17M shares outstanding (Aug 5, 2026), -0.1% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
KRMD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.03 | 3.06 | 2.96 | 3.00 | 165.23K |
| Oct 15, 2026 | 3.12 | 3.14 | 2.97 | 3.03 | 203.20K |
| Oct 14, 2026 | 2.97 | 3.11 | 2.89 | 3.11 | 315.70K |
| Oct 13, 2026 | 2.97 | 3.05 | 2.93 | 3.00 | 318.00K |
| Oct 12, 2026 | 2.96 | 2.97 | 2.87 | 2.97 | 162.90K |
| Oct 9, 2026 | 2.99 | 3.07 | 2.94 | 2.96 | 202.60K |
| Oct 8, 2026 | 2.97 | 3.05 | 2.95 | 3.00 | 235.90K |
| Oct 7, 2026 | 2.98 | 3.05 | 2.96 | 2.98 | 111.00K |
| Oct 6, 2026 | 3.02 | 3.02 | 2.95 | 3.00 | 129.10K |
| Oct 5, 2026 | 2.99 | 3.03 | 2.91 | 3.01 | 206.40K |
| Oct 2, 2026 | 3.11 | 3.26 | 2.94 | 2.96 | 273.50K |
| Oct 1, 2026 | 2.94 | 3.04 | 2.86 | 3.02 | 280.40K |
| Sep 30, 2026 | 3.02 | 3.02 | 2.90 | 2.93 | 265.70K |
| Sep 29, 2026 | 3.04 | 3.05 | 2.98 | 3.01 | 243.10K |
| Sep 28, 2026 | 3.21 | 3.24 | 3.02 | 3.06 | 226.70K |
| Sep 25, 2026 | 3.27 | 3.30 | 2.99 | 3.21 | 368.60K |
| Sep 24, 2026 | 3.26 | 3.29 | 3.18 | 3.27 | 357.00K |
| Sep 23, 2026 | 3.31 | 3.39 | 3.20 | 3.27 | 465.60K |
| Sep 22, 2026 | 3.25 | 3.33 | 3.20 | 3.31 | 611.50K |
| Sep 21, 2026 | 3.23 | 3.27 | 3.20 | 3.23 | 265.30K |
About KORU Medical Systems
KORU Medical Systems (KRMD) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in MAHWAH, NJ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 704440.
KRMD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Robert Cascella | Director | Jul 1, 2026 |
| R John Fletcher | Chairman of the Board | Jul 1, 2026 |
| Donna French | Director | Jul 1, 2026 |
| Joseph M. Jr. Manko | Director | Jul 1, 2026 |
| Shahriar Matin | Director | Jul 1, 2026 |
| Linda M Tharby | Chief Executive Officer | May 20, 2026 |
| Edward Wholihan | Director | Jul 1, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Thomas Edward Adams | Chief Financial Officer | May 18, 2026 |
| Adam R Kalbermatten | Chief Commercial Officer | Sep 9, 2026 |
| Christopher Pazdan | Chief Operating Officer | May 18, 2026 |
| Eric Schiller | Chief Technology Officer | May 20, 2026 |
| Linda M Tharby | Chief Executive Officer | May 20, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 8, 2026 | Adam R Kalbermatten | Buy | 32,000 | $3.16 |
| Sep 8, 2026 | Adam R Kalbermatten | Buy | 32,000 | $3.16 |
| Sep 8, 2026 | Adam R Kalbermatten | Buy | 32,000 | $3.16 |
| Sep 8, 2026 | Adam R Kalbermatten | Buy | 32,000 | $3.16 |
| Jun 11, 2026 | Adam R Kalbermatten | Buy | 7,500 | $3.93 |
| Jun 11, 2026 | Adam R Kalbermatten | Buy | 5,000 | $3.96 |
| Jun 11, 2026 | Adam R Kalbermatten | Buy | 7,500 | $3.93 |
| Jun 11, 2026 | Adam R Kalbermatten | Buy | 5,000 | $3.96 |
| Jun 11, 2026 | Adam R Kalbermatten | Buy | 7,500 | $3.93 |
| Jun 11, 2026 | Adam R Kalbermatten | Buy | 5,000 | $3.96 |
| Jun 11, 2026 | Adam R Kalbermatten | Buy | 7,500 | $3.93 |
| Jun 11, 2026 | Adam R Kalbermatten | Buy | 5,000 | $3.96 |
| May 18, 2026 | Eric Schiller | Buy | 5,000 | $3.91 |
| May 18, 2026 | Eric Schiller | Buy | 5,000 | $3.91 |
| May 18, 2026 | Eric Schiller | Buy | 5,000 | $3.91 |
KRMD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $41.13M | $-2.64M | -0.06 | $462.40K |
| Dec 31, 2024 | $33.65M | $-6.07M | -0.13 | $-319.72K |
| Dec 31, 2023 | $28.52M | $-13.74M | -0.30 | $-4.89M |
| Dec 31, 2022 | $27.90M | $-8.66M | -0.19 | $-5.40M |
| Dec 31, 2021 | $23.49M | $-4.56M | -0.10 | $-4.32M |
Latest balance sheet: total assets $27.96M, total liabilities $9.91M, cash $8.29M (as of Jun 30, 2026).
KRMD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $4.13 |
| May 6, 2026 | 8-K Item 2.02 (results) | $4.01 |
| Mar 12, 2026 | 8-K Item 2.02 (results) | $4.31 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $5.89 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $3.78 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $3.26 |
| May 7, 2025 | 8-K Item 2.02 (results) | $2.72 |
| Mar 12, 2025 | 8-K Item 2.02 (results) | $3.28 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $3.95 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $3.20 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 1, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on KRMD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.